Soman - GD
Nerve Agent
(Pinacolyl methyl phosphonofluoridate)

Description:

Soman was discovered in Germany in 1944. GD is a lethal cholinesterase inhibitor. Doses that are potentially life threatening may be only slightly larger than those producing least effects. Soman is a colorless liquid when pure with a fruity odor. The industrial version is yellow-brown with a camphor-like odor.

Signs and Symptoms:

Symptoms of overexposure may occur within minutes or hours, depending upon dose. They include: miosis (constriction of pupils) and visual effects, headaches and pressure sensation, runny nose and nasal congestion, salivation, tightness in the chest, nausea, vomiting, giddiness, anxiety, difficulty in thinking and sleeping, nightmares, muscle twitches, tremors, weakness, abdominal cramps, diarrhea, involuntary urination and defecation. Severe exposure symptoms progress to convulsions and respiratory failure.

Treatment:

Inhalation: Hold breath until respiratory protective mask is donned. If severe signs of agent exposure appear (chest tightens, pupil constriction, in coordination, etc.), immediately administer, in rapid succession, all three Nerve Agent Antidote Kit(s), Mark I injectors (or atropine if directed by a physician). Injections using the Mark I kit injectors may be repeated at 5 to 20 minute intervals if signs and symptoms are progressing until three series of injections have been administered. No more injections will be given unless directed by medical personnel. In addition, a record will be maintained of all injections given. If breathing has stopped, give artificial respiration. Mouth-to-mouth resuscitation should be used when mask-bag or oxygen delivery systems are not available. Do not use mouth-to-mouth resuscitation when facial contamination exists. If breathing is difficult, administer oxygen. Seek medical attention Immediately.
Eye Contact: Immediately flush eyes with water for 10-15 minutes, then don respiratory protective mask. Although miosis (pinpointing of the pupils) may be an early sign of agent exposure, an injection will not be administered when miosis is the only sign present. Instead, the individual will be taken Immediately to a medical treatment facility for observation.
Skin Contact: Don respiratory protective mask and remove contaminated clothing. Immediately wash contaminated skin with copious amounts of soap and water, 10% sodium carbonate solution, or 5% liquid household bleach. Rinse well with water to remove excess decontaminant. Administer nerve agent antidote kit, Mark I, only if local sweating and muscular twitching symptoms are observed. Seek medical attention Immediately. Ingestion: Do not induce vomiting. First symptoms are likely to be gastrointestinal. Immediately administer Nerve Agent Antidote Kit, Mark I. Seek medical attention Immediately.